Company news
Nautilus Biotechnology, Inc. news in 2023
Nautilus Biotechnology, Inc.'s news releases, calls and decks from 2023, newest first.
Nautilus Biotechnology Appoints Martin Huber, Ph.D., as Vice President of Biochemistry and Flow Cell Development
October 31, 2023
Nautilus Biotechnology Reports Third Quarter 2023 Financial Results
October 30, 2023
Nautilus Biotechnology to Announce Third Quarter Financial Results on October 31, 2023
October 10, 2023
Nautilus Biotechnology Reports Second Quarter 2023 Financial Results
August 1, 2023
Nautilus Biotechnology to Announce Second Quarter Financial Results on August 2, 2023
July 10, 2023
Nautilus Biotechnology Reports First Quarter 2023 Financial Results
May 1, 2023
Nautilus Biotechnology to Announce First Quarter Financial Results on May 2, 2023
April 17, 2023
Nautilus Biotechnology Announces “First Access Challenge” Winners
March 6, 2023
Nautilus Biotechnology Reports Fourth Quarter and Fiscal Year 2022 Financial Results
February 22, 2023
Nautilus Biotechnology to Announce Fourth Quarter and Full Year 2022 Financial Results on February 23, 2023
January 25, 2023
Nautilus Biotechnology Expands to San Diego
January 25, 2023
Nautilus Biotechnology Partners with the Translational Genomics Research Institute (TGen) to Investigate Applications of Single-Molecule Proteomic Analysis in Diffuse Intrinsic Pontine Glioma (DIPG)
January 18, 2023
Calls in 2023
- Nautilus Biotechnology (NASDAQ:NAUT) Q3 2023 Earnings Call
Oct 31, 2023
Transcript - Nautilus Biotechnology (NASDAQ:NAUT) Q2 2023 Earnings Call
Aug 2, 2023
Transcript - Nautilus Biotechnology (NASDAQ:NAUT) Q1 2023 Earnings Call
May 2, 2023
Transcript - Nautilus Biotechnology (NASDAQ:NAUT) Q4 2022 Earnings Call
Feb 23, 2023
Transcript